tiprankstipranks
Prescient Therapeutics Limited (AU:PTX)
ASX:PTX
Australian Market
PTX
Prescient Therapeutics Limited
RESEARCH TOOLSreports

Prescient Therapeutics Limited (PTX) Cash flow

17 Followers

Prescient Therapeutics Limited Cash Flow

AU:PTX's free cash flow for Q2 2026 was AU$-6.54M. For the 2026 fiscal year, AU:PTX's free cash flow was decreased by AU$154.40K and operating cash flow was AU$-6.54M. See a summary of the company’s cash flow.
Cash Flow
Jun 25Jun 24Jun 23Jun 22Jun 21
Operating Cash Flow
AU$ -7.24MAU$ -7.40MAU$ -6.19MAU$ -4.31MAU$ -3.97M
Investing Cash Flow
AU$ 4.00MAU$ 12.00MAU$ -16.00MAU$ -4.43KAU$ -2.31K
Financing Cash Flow
AU$ -330.49KAU$ 18.15KAU$ 15.83MAU$ 428.29KAU$ 12.75M
End Cash Position
AU$ 6.91MAU$ 10.49MAU$ 5.90MAU$ 12.26MAU$ 16.10M
Free Cash Flow
AU$ -7.24MAU$ -7.40MAU$ -6.19MAU$ -4.32MAU$ -3.97M
Currency in AUD

Prescient Therapeutics Limited Cash Flow